China okays Sinopharm’s 2nd jab for people aged 3-17

Chinese health regulators approved on Wednesday the COVID-19 vaccine developed by a Wuhan-based affiliate of China National Pharmaceutical Group, also known as Sinopharm, for use on children and adole…